A cross-section of the spinal cord showing neurons and glial cells. (Juan Carlos Juarez Jaramillo/iStock/Getty Images Plus) A ...

If you’ve been recently diagnosed with SPMS, you may wonder how the transition between RRMS and SPMS will affect your MS treatment options and lifestyle. Most people with MS are initially diagnosed ...

As recently as the ‘90s, when patients arrived with all the typical symptoms — memory loss, double vision, fatigue — neurologists often avoided confirming what they most suspected: that the patient ...

A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a ...

The Wistar Institute's Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author Samantha Soldan, Ph.D., have demonstrated how B cells infected with the Epstein-Barr virus ...

Multiple sclerosis is an autoimmune condition that affects the nervous system, leading to nerve damage and chronic inflammation. While the exact cause of this disorder is unknown, experts believe ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. March is Multiple Sclerosis Awareness Month, a time to ...

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...

Multiple Sclerosis is an autoimmune disease that affects the central nervous system.

PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...

Many women with multiple sclerosis (MS) have misconceptions about how the disease may affect pregnancy and childbirth, a ...

Three Indians share how Multiple Sclerosis impacted careers, motherhood, and independence — and how timely treatment helped ...